|
1
|
Areia M, Carvalho R, Cadime AT, Goncalves
Rocha F and Dinis-Ribeiro M: Screening for gastric cancer and
surveillance of premalignant lesions: A systematic review of
cost-effectiveness studies. Helicobacter. 18:325–337. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Futtrup TB, Hasselby JP and Baeksgaard L:
Gastric signet ring cell carcinoma presenting as diffuse,
infiltrating myositis-a case report and review of the literature. J
Gastrointest Cancer. 45 Suppl 1:S62–S65. 2014. View Article : Google Scholar
|
|
3
|
Pimenta-Melo AR, Monteiro-Soares M,
Libanio D and Dinis-Ribeiro M: Missing rate for gastric cancer
during upper gastrointestinal endoscopy: A systematic review and
meta-analysis. Eur J Gastroenterol Hepatol. 28:1041–1049. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Veisani Y and Delpisheh A: Survival rate
of gastric cancer in Iran; a systematic review and meta-analysis.
Gastroenterol Hepatol Bed Bench. 9:78–86. 2016.PubMed/NCBI
|
|
5
|
Jung SA, Park YM, Hong SW, Moon JH, Shin
JS, Lee HR, Ha SH, Lee DH, Kim JH, Kim SM, et al: Cellular
inhibitor of apoptosis protein 1 (cIAP1) stability contributes to
YM155 resistance in human gastric cancer cells. J Biol Chem.
290:9974–9985. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Izawa M, Mori T, Satoh T, Teramachi K and
Sairenji T: Identification of an alternative form of caspase-9 in
human gastric cancer cell lines: A role of a caspase-9 variant in
apoptosis resistance. Apoptosis. 4:321–325. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oberstein PE, Kenney B, Krishnamoorthy SK,
Woo Y and Saif MW: Metastatic gastric large cell neuroendocrine
carcinoma: A case report and review of literature. Clin Colorectal
Cancer. 11:218–223. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li K and Li J: Current molecular targeted
therapy in advanced gastric cancer: A comprehensive review of
therapeutic mechanism, clinical trials, and practical application.
Gastroenterol Res Pract. 2016:41056152016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruzzo A, Catalano V, Canestrari E,
Giacomini E, Santini D, Tonini G, Vincenzi B, Fiorentini G, Magnani
M and Graziano F: Genetic modulation of the interleukin 6 (IL-6)
system in patients with advanced gastric cancer: A background for
an alternative target therapy. BMC Cancer. 14:3572014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Thews O, Riemann A, Nowak M and Gekle M:
Impact of hypoxia-related tumor acidosis on cytotoxicity of
different chemotherapeutic drugs in vitro and in vivo. Adv Exp Med
Biol. 812:51–58. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fujikuni N, Yamamoto H, Tanabe K, Naito Y,
Sakamoto N, Tanaka Y, Yanagihara K, Oue N, Yasui W and Ohdan H:
Hypoxia-mediated CD24 expression is correlated with gastric cancer
aggressiveness by promoting cell migration and invasion. Cancer
Sci. 105:1411–1420. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miao ZF, Wang ZN, Zhao TT, Xu YY, Gao J,
Miao F and Xu HM: Peritoneal milky spots serve as a hypoxic niche
and favor gastric cancer stem/progenitor cell peritoneal
dissemination through hypoxia-inducible factor 1α. Stem Cells.
32:3062–3074. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matsuoka J, Yashiro M, Doi Y, Fuyuhiro Y,
Kato Y, Shinto O, Noda S, Kashiwagi S, Aomatsu N, Hirakawa T, et
al: Hypoxia stimulates the EMT of gastric cancer cells through
autocrine TGFβ signaling. PLoS One. 8:e623102013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun XP, Dong X, Lin L, Jiang X, Wei Z,
Zhai B, Sun B, Zhang Q, Wang X, Jiang H, et al: Up-regulation of
survivin by AKT and hypoxia-inducible factor 1α contributes to
cisplatin resistance in gastric cancer. FEBS J. 281:115–128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Osinsky S, Bubnovskaya L, Ganusevich I,
Kovelskaya A, Gumenyuk L, Olijnichenko G and Merentsev S: Hypoxia,
tumour-associated macrophages, microvessel density, VEGF and matrix
metalloproteinases in human gastric cancer: Interaction and impact
on survival. Clin Transl Oncol. 13:133–138. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marwitz S, Depner S, Dvornikov D, Merkle
R, Szczygieł M, Müller-Decker K, Lucarelli P, Wäsch M, Mairbäurl H,
Rabe KF, et al: Downregulation of the TGFβ pseudoreceptor BAMBI in
non-small cell lung cancer enhances TGFβ signaling and invasion.
Cancer Res. 76:3785–3801. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Legg K: Autoimmunity: A controlled
performance by BAMBI. Nat Rev Rheumatol. 12:722016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miao S, Zhao L, Gao J, Wang H and Cui Z:
Distribution and mRNA expression of BAMBI in Non-small-cell lung
cancer. Zhongguo Fei Ai Za Zhi. 12:203–207. 2009.(In Chinese).
PubMed/NCBI
|
|
19
|
Fritzmann J, Morkel M, Besser D, Budczies
J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM and
Birchmeier W: A colorectal cancer expression profile that includes
transforming growth factor beta inhibitor BAMBI predicts metastatic
potential. Gastroenterology. 137:165–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khin SS, Kitazawa R, Win N, Aye TT, Mori
K, Kondo T and Kitazawa S: BAMBI gene is epigenetically silenced in
subset of high-grade bladder cancer. Int J Cancer. 125:328–338.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pils D, Wittinger M, Petz M, Gugerell A,
Gregor W, Alfanz A, Horvat R, Braicu EI, Sehouli J, Zeillinger R,
et al: BAMBI is overexpressed in ovarian cancer and co-translocates
with Smads into the nucleus upon TGF-beta treatment. Gynecol Oncol.
117:189–197. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu K, Song X, Ma H, Liu L, Wen X, Yu J,
Wang L and Hu S: Knockdown of BAMBI inhibits β-catenin and
transforming growth factor β to suppress metastasis of gastric
cancer cells. Mol Med Rep. 10:874–880. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang Y, Yu Z, Xiao Q, Sun X, Zhu Z, Zhang
J, Xu H, Wei M and Sun M: Expression of BAMBI and its combination
with Smad7 correlates with tumor invasion and poor prognosis in
gastric cancer. Tumour Biol. 35:7047–7056. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foley PL: Current options for providing
sustained analgesia to laboratory animals. Lab Anim (NY).
43:364–371. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng L, Liang W, Pan J, Cao Y, Liu J, Wang
Q, Wang L, Zou Y, Wang K, Kong L, et al: Do Chinese researchers
conduct ethical research and use ethics committee review in
clinical trials of Anti-dementia drugs? An analysis of biomedical
publications originating from China. J Alzheimers Dis. 52:813–823.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Luo L, Zhong H, Liu S, Deng L, Luo Y,
Zhang Q, Zhu Y, Tian Y, Sun Y and Tian X: Intracellular ‘activated’
two-photon photodynamic therapy by fluorescent conveyor and
photosensitizer co-encapsulating pH-responsive micelles against
breast cancer. Int J Nanomedicine. 12:5189–5201. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scherer O, Maeß MB, Lindner S, Garscha U,
Weinigel C, Rummler S, Werz O and Lorkowski S: A procedure for
efficient non-viral siRNA transfection of primary human monocytes
using nucleofection. J Immunol Methods. 422:118–124. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Babiker HA, Saito T, Nakatsu Y, Takasuga
S, Morita M, Sugimoto Y, Ueda J and Watanabe T: Molecular cloning,
polymorphism, and functional activity of the bovine and water
buffalo Mx2 gene promoter region. Springerplus. 5:21092016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Renshaw A and Elsheikh TM: A validation
study of the Focalpoint GS imaging system for gynecologic cytology
screening. Cancer Cytopathol. 121:737–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Joubert BR, Felix JF, Yousefi P, Bakulski
KM, Just AC, Breton C, Reese SE, Markunas CA, Richmond RC, Xu CJ,
et al: DNA methylation in newborns and maternal smoking in
pregnancy: Genome-wide consortium Meta-analysis. Am J Hum Genet.
98:680–696. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Iijima K and Kiyokawa N: Analysis of gene
expression and DNA methylation patterns in childhood acute
lymphoblastic leukemia. Rinsho Ketsueki. 57:425–429. 2016.(In
Japanese). PubMed/NCBI
|
|
32
|
Yaghoubi A, Aryan E, Zare H, Alami SH,
Teimourpour R and Meshkat Z: Design and construction of a cloning
vector containing the hspX gene of mycobacterium tuberculosis. Rep
Biochem Mol Biol. 5:46–50. 2016.PubMed/NCBI
|
|
33
|
Koole K, Clausen MJ, van Es RJ, van Kempen
PM, Melchers LJ, Koole R, Langendijk JA, van Diest PJ, Roodenburg
JL, Schuuring E and Willems SM: Fgfr family members protein
expression as prognostic markers in oral cavity and oropharyngeal
squamous cell carcinoma. Mol Diagn Ther. 20:363–374. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakamoto A, Akiyama Y, Shimada S, Zhu WG,
Yuasa Y and Tanaka S: DNA methylation in the Exon 1 region and
complex regulation of Twist1 expression in gastric cancer cells.
PLoS One. 10:e01456302015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Choi HS, Ha SY, Kim HM, Ahn SM, Kang MS,
Kim KM, Choi MG, Lee JH, Sohn TS, Bae JM, et al: The prognostic
effects of tumor infiltrating regulatory T cells and myeloid
derived suppressor cells assessed by multicolor flow cytometry in
gastric cancer patients. Oncotarget. 7:7940–7951. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mori F, Canu V, Lorenzon L, Garofalo A,
Blandino G and Strano S: Cancer gastric chemoprevention: Isolation
of gastric Tumor-initiating cells. Methods Mol Biol. 1379:129–137.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park D II, Son HJ, Song SY, Choe WH, Lim
YJ, Park SJ, Kim JJ, Kim YH, Rhee PL, Paik SW, et al: Role of
TGF-beta 1 and TGF-beta type II receptor in gastric cancer. Korean
J Intern Med. 17:160–166. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Morita K, Fujimori T, Ono Y, Hiraishi H,
Yoshiura K, Shimada T, Sugaya H and Terano A: Identification of the
prelinitis condition in gastric cancer and analysis of TGF-beta,
TGF-beta RII and pS2 expression. Pathobiology. 69:321–328. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Muhrer KH, Schwemmle K, Stambolis C and
Kahle M: KCl-tumor extracts in the electrophoretic mobility test
[EMT]. -Clinical relevance to diagnosis of gastric cancer (author's
transl). Z Gastroenterol. 20:376–383. 1982.(In German). PubMed/NCBI
|
|
40
|
Donatelli SS, Zhou JM, Gilvary DL,
Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D,
Wei S and Djeu JY: TGF-β-inducible microRNA-183 silences
tumor-associated natural killer cells. Proc Natl Acad Sci USA.
111:4203–4208. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ohnuki H, Jiang K, Wang D, Salvucci O,
Kwak H, Sánchez-Martín D, Maric D and Tosato G: Tumor-infiltrating
myeloid cells activate Dll4/Notch/TGF-β signaling to drive
malignant progression. Cancer Res. 74:2038–2049. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fu H, Hu Z, Wen J, Wang K and Liu Y:
TGF-beta promotes invasion and metastasis of gastric cancer cells
by increasing fascin1 expression via ERK and JNK signal pathways.
Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guan Z, Song B, Liu F, Sun D, Wang K and
Qu H: TGF-β induces HLA-G expression through inhibiting miR-152 in
gastric cancer cells. J Biomed Sci. 22:1072015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Gu J, Qian H, Shen L, Zhang X, Zhu W,
Huang L, Yan Y, Mao F, Zhao C, Shi Y and Xu W: Gastric cancer
exosomes trigger differentiation of umbilical cord derived
mesenchymal stem cells to carcinoma-associated fibroblasts through
TGF-β/Smad pathway. PLoS One. 7:e524652012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma Y, Liu H, Zhang H and Shao RG: The
TGF-β signaling pathway induced EMT in breast cancer. Yao Xue Xue
Bao. 50:385–392. 2015.(In Chinese). PubMed/NCBI
|
|
46
|
Elsum IA, Martin C and Humbert PO:
Scribble regulates an EMT polarity pathway through modulation of
MAPK-ERK signaling to mediate junction formation. J Cell Sci.
126:3990–3999. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Willis BC and Borok Z: TGF-beta-induced
EMT: Mechanisms and implications for fibrotic lung disease. Am J
Physiol Lung Cell Mol Physiol. 293:L525–L534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li Y, Ma J, Qian X, Wu Q, Xia J, Miele L,
Sarkar FH and Wang Z: Regulation of EMT by Notch signaling pathway
in tumor progression. Curr Cancer Drug Targets. 13:957–962. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Pak KH, Kim DH, Kim H, Lee DH and Cheong
JH: Erratum to: Differences in TGF-β1 signaling and
clinicopathologic characteristics of histologic subtypes of gastric
cancer. BMC Cancer. 16:992016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sekiya T, Adachi S, Kohu K, Yamada T,
Higuchi O, Furukawa Y, Nakamura Y, Nakamura T, Tashiro K, Kuhara S,
et al: Identification of BMP and activin membrane-bound inhibitor
(BAMBI), an inhibitor of transforming growth factor-beta signaling,
as a target of the beta-catenin pathway in colorectal tumor cells.
J Biol Chem. 279:6840–6846. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kitazawa S, Kitazawa R, Obayashi C and
Yamamoto T: Desmoid tumor with ossification in chest wall: Possible
involvement of BAMBI promoter hypermethylation in metaplastic bone
formation. J Bone Miner Res. 20:1472–1477. 2005. View Article : Google Scholar : PubMed/NCBI
|
